 Single-dose versus fractionated-dose dactinomycin treatment Wilms tumor Preliminary results clinical trial Brazilian Wilms Tumor Study Group clinical trial Brazilian Wilms Tumor WT Study Group single-dose micrograms/kg day administration dactinomycin AMD standard dose micrograms/kg/d days US National WT Study AMD administration treatment patients latter study Patients AMD regimens schedules stage histologic condition seventy-six children WT study December significant differences overall relapse-free survival distributions treatment arms data patients data disease stage Two-year survival rates patients single doses AMD Survival distributions patients protocol violations overall survival rates relapse-free survival rates fractionated single AMD doses Altered liver function patients dose patients single AMD dose Acute toxicity patient fractionated-dose group patients single-dose group closing date patients AMD regimen days hospital stay standard regimen